Dolutegravir/lamivudine - Wikipedia
网页Dolutegravir/lamivudine, sold under the brand name Dovato, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. each pill contains 50 mg dolutegravir, as the salt, an integrase strand transfer inhibitor (INSTI), and 300 mg lamivudine, a nucleoside analogue reverse transcriptase inhibitor (NRTI).
FDA approves first two-drug complete regimen for HIV-infected …
网页The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in...
Dovato (dolutegravir + lamivudine) | Guides | HIV i-Base
网页Dovato is a two-drug Fixed Dose Combination (FDC) containing 50 mg dolutegravir plus 300 mg lamivudine (3TC) It is approved in the US for people who are using HIV treatment for the first time and who do not have resistance to either dolutegravir or lamivudine. Dovato can be taken with or without food.
网页What is Dovato? A film coated tablet that is white and oval shaped with “SV 137” on one side. Dovato is a combination tablet of two drugs: . 1. Dolutegravir which belongs to a group of anti-HIV drugs called integrase inhibitors. 2.
网页Dovato is a medicine for treating infection with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). It is used to treat adults and adolescents over 12 years old who weigh at least 40 kg.
网页DOVATO, dolutegravir sodium and lamivudine June 2023 Page 4 of 46 PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS DOVATO (dolutegravir and lamivudine) is indicated as a complete regimen for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents 12 …
Dovato HCP
网页DOVATO is indicated as a complete regimen to treat HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 25 kg with no antiretroviral (ARV) treatment history or to replace the current ARV regimen in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable ARV regimen with no history of ...
Dovato - European Medicines Agency (EMA)
网页Dovato is a medicine for treating infection with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). It is used to treat adults and adolescents over 12 years old who weigh at least 40 kg.
Lamivudine with dolutegravir | Drugs | BNF | NICE
网页Dolutegravir / lamivudine (Dovato®) for treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine (September 2019)
Dovato for HIV Treatment - H-I-V.net
网页Dovato is a combination medication that contains dolutegravir, and lamivudine. It is used on its own as a standalone antiretroviral therapy (ART) regimen for HIV-1 in adults with no previous HIV antiviral treatment history.
- 某些结果已被删除